ID Name Structure References (top 5) Molecular Target(s)
1ID:2386
FOLIC ACID


NSC#:3073(<1uM)
Aldrich#:47620
Aldrich#:S579270
FDA approved!!!

Freqency:
in 3 ingredients:

  • 5
  • 233
  • 614
  • in 48 recipes:

  • 8
  • 18
  • 47
  • 49
  • 58
  • 87
  • 91
  • 102
  • 107
  • 110
  • 115
  • 123
  • 131
  • 155
  • 156
  • 161
  • 170
  • 190
  • 203
  • 212
  • 227
  • 236
  • 244
  • 247
  • 271
  • 272
  • 280
  • 294
  • 301
  • 308
  • 312
  • 338
  • 340
  • 351
  • 367
  • 382
  • 410
  • 438
  • 441
  • 443
  • 446
  • 448
  • 449
  • 458
  • 459
  • 473
  • 515
  • 522

  • Properties
    C19H19N7O6    441.4





    1:  Hu FB, Willett WC.
    Optimal diets for prevention of coronary heart disease.
    JAMA.    impact factor:   15.402
    2002;  288(20): 2569-78

    2:  Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE.
    Association of neural tube defects and folic acid food fortification in Canada.
    Lancet.    impact factor:   10.197
    2002;  360(9350): 2047-8

    3:  Chan NN, Chan WB, Chan JC.
    Reduction of total homocysteine levels by oral folic acid fails to improve endothelial function in children with chronic renal failure.
    Circulation.    impact factor:   9.903
    2003;  107(1): e6-7; author reply e6-7

    4:  Wang Y, Zhao R, Chattopadhyay S, Goldman ID.
    A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexed.
    Cancer Res.    impact factor:   8.614
    2002;  62(22): 6434-7

    5:  Louvet C, Andre T, Tigaud JM, Gamelin E, Douillard JY, Brunet R, Francois E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, de Gramont A.
    Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.
    J Clin Oncol.    impact factor:   7.963
    2002;  20(23): 4543-8

     
    Time used: 109 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005